447 related articles for article (PubMed ID: 11867523)
1. Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma.
Nanbo A; Inoue K; Adachi-Takasawa K; Takada K
EMBO J; 2002 Mar; 21(5):954-65. PubMed ID: 11867523
[TBL] [Abstract][Full Text] [Related]
2. Protection from interferon-induced apoptosis by Epstein-Barr virus small RNAs is not mediated by inhibition of PKR.
Ruf IK; Lackey KA; Warudkar S; Sample JT
J Virol; 2005 Dec; 79(23):14562-9. PubMed ID: 16282456
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction.
Kitagawa N; Goto M; Kurozumi K; Maruo S; Fukayama M; Naoe T; Yasukawa M; Hino K; Suzuki T; Todo S; Takada K
EMBO J; 2000 Dec; 19(24):6742-50. PubMed ID: 11118209
[TBL] [Abstract][Full Text] [Related]
4. The role of Epstein-Barr virus-encoded small RNAs (EBERs) in oncogenesis.
Nanbo A; Takada K
Rev Med Virol; 2002; 12(5):321-6. PubMed ID: 12211044
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of an epstein-barr virus-positive tumor line, Daudi, to alpha interferon correlates with expression of a GC-rich viral transcript.
Gao Y; Xue Sa; Griffin BE
Mol Cell Biol; 1999 Nov; 19(11):7305-13. PubMed ID: 10523619
[TBL] [Abstract][Full Text] [Related]
6. Modulation of innate immunity system by Epstein-Barr virus-encoded non-coding RNA and oncogenesis.
Samanta M; Takada K
Cancer Sci; 2010 Jan; 101(1):29-35. PubMed ID: 19886912
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata.
Komano J; Maruo S; Kurozumi K; Oda T; Takada K
J Virol; 1999 Dec; 73(12):9827-31. PubMed ID: 10559294
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata.
Komano J; Sugiura M; Takada K
J Virol; 1998 Nov; 72(11):9150-6. PubMed ID: 9765461
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma.
Niedobitek G; Agathanggelou A; Rowe M; Jones EL; Jones DB; Turyaguma P; Oryema J; Wright DH; Young LS
Blood; 1995 Jul; 86(2):659-65. PubMed ID: 7605996
[TBL] [Abstract][Full Text] [Related]
10. Malignant transformation of B lymphoma cell line BJAB by Epstein-Barr virus-encoded small RNAs.
Yamamoto N; Takizawa T; Iwanaga Y; Shimizu N; Yamamoto N
FEBS Lett; 2000 Nov; 484(2):153-8. PubMed ID: 11068051
[TBL] [Abstract][Full Text] [Related]
11. Replacement of the Epstein-Barr virus plasmid with the EBER plasmid in Burkitt's lymphoma cells.
Maruo S; Nanbo A; Takada K
J Virol; 2001 Oct; 75(20):9977-82. PubMed ID: 11559830
[TBL] [Abstract][Full Text] [Related]
12. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
13. Epstein-barr virus-induced resistance to drugs that activate the mitotic spindle assembly checkpoint in Burkitt's lymphoma cells.
Leao M; Anderton E; Wade M; Meekings K; Allday MJ
J Virol; 2007 Jan; 81(1):248-60. PubMed ID: 17035311
[TBL] [Abstract][Full Text] [Related]
14. Role of Epstein-Barr virus in Burkitt's lymphoma.
Takada K
Curr Top Microbiol Immunol; 2001; 258():141-51. PubMed ID: 11443859
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
De Leo A; Arena G; Stecca C; Raciti M; Mattia E
Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-encoded poly(A)- RNA confers resistance to apoptosis mediated through Fas by blocking the PKR pathway in human epithelial intestine 407 cells.
Nanbo A; Yoshiyama H; Takada K
J Virol; 2005 Oct; 79(19):12280-5. PubMed ID: 16160154
[TBL] [Abstract][Full Text] [Related]
17. The role of EBERs in oncogenesis.
Takada K; Nanbo A
Semin Cancer Biol; 2001 Dec; 11(6):461-7. PubMed ID: 11669608
[TBL] [Abstract][Full Text] [Related]
18. Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase.
Gale M; Kwieciszewski B; Dossett M; Nakao H; Katze MG
J Virol; 1999 Aug; 73(8):6506-16. PubMed ID: 10400746
[TBL] [Abstract][Full Text] [Related]
19. Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma.
Toomey NL; Deyev VV; Wood C; Boise LH; Scott D; Liu LH; Cabral L; Podack ER; Barber GN; Harrington WJ
Oncogene; 2001 Oct; 20(48):7029-40. PubMed ID: 11704827
[TBL] [Abstract][Full Text] [Related]
20. EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN.
Samanta M; Iwakiri D; Kanda T; Imaizumi T; Takada K
EMBO J; 2006 Sep; 25(18):4207-14. PubMed ID: 16946700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]